Ferinject 500mg 10ml vial represents a targeted iron replacement option used when oral supplementation is insufficient or poorly tolerated. This ready-to-use vial is designed for clinical settings where precise dosing and rapid replenishment of iron stores are required.
Understanding the formulation, storage conditions, and administration workflow helps ensure safe and effective use. The following sections explore product specifications, clinical considerations, and practical guidance for healthcare professionals.
| Product Name | Ferinject 500mg 10ml Vial | Concentration | 50 mg iron per ml |
|---|---|---|---|
| Iron Salt | Iron Carboxymaltose | Total Iron per Vial | 500 mg |
| Volume | 10 ml | Vehicle/Solvent | Water for injections |
| Intended Use | Intravenous iron replacement | Prescription Status | Prescription only |
| Storage Temperature | Store below 25°C | Shelf Life | Varies by region; check label |
Product identity and classification
Ferinject 500mg 10ml vial is classified as an intravenous iron therapy, specifically iron carboxymaltose. It is not a medication for immediate symptom relief but rather a targeted approach to replenish iron stores in patients with iron deficiency.
Clinicians rely on standardized labeling, batch information, and verified supplier channels to ensure product authenticity. Accurate identification supports appropriate use and minimizes administration errors in clinical practice.
Indications and patient selection
This formulation is indicated when oral iron therapy is ineffective, not tolerated, or when rapid iron repletion is clinically necessary. Conditions such as chronic kidney disease, inflammatory bowel disease, and postoperative recovery may warrant consideration under medical supervision.
Patient selection should include a thorough assessment of iron status, underlying etiology, and potential contraindications. Proper evaluation helps align therapeutic goals with individual patient needs and safety profiles.
Dosage, administration, and monitoring
Dosing is weight-based and condition-specific, with infusion protocols tailored to achieve target iron levels while minimizing risk. Administering via slow intravenous infusion allows for controlled delivery and observation for any acute reactions during the procedure.
Monitoring includes baseline assessments of iron parameters and follow-up measurements to confirm response. Regular evaluation supports dose adjustments and helps avoid issues related to overcorrection or insufficient replenishment.
Safety considerations and precautions
Potential adverse effects include infusion-related reactions, hypersensitivity, and minor local reactions at the injection site. Pre-medication is not routinely required but may be considered based on individual patient risk factors and clinician judgment.
Contraindications generally involve known hypersensitivity to iron components or excipients. A detailed patient history and careful observation during and after infusion contribute to safe use and timely intervention if needed.
Key takeaways and recommendations
- Confirm iron deficiency with appropriate laboratory tests before initiating Ferinject.
- Follow weight-based dosing and institutional protocols during administration.
- Monitor hemoglobin and iron parameters at defined intervals to assess response.
- Report any infusion-related symptoms promptly to your healthcare provider.
- Store and handle vials according to labeled conditions to maintain product integrity.
FAQ
Reader questions
How quickly is iron repletion expected after a single dose of Ferinject 500mg?
Hemoglobin improvements may be observed within one to two weeks, though full iron repletion can take several weeks depending on baseline stores and ongoing losses. Serial laboratory monitoring guides further dosing decisions.
What should I do if I miss a scheduled Ferinject appointment?
Contact your healthcare provider to reschedule. They will assess whether a delay affects your iron status and will recommend an adjusted schedule to maintain adequate repletion without increasing risk.
Can Ferinject 500mg 10ml vial be used during pregnancy?
Use during pregnancy is considered when benefits outweigh potential risks, typically in cases of significant iron deficiency. Treatment should be supervised by a clinician experienced in obstetric care and pharmacotherapy.
Are there specific lab tests required before starting Ferinject?
Yes, baseline tests including serum ferritin, transferrin saturation, and hemoglobin are commonly used to confirm deficiency and guide dosing. Follow-up testing helps evaluate response and refine subsequent doses.